Delivery Order SPE2DB20D9156-SPE2DB25FH28M
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on July 26, 2025, with an ultimate completion date of July 28, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $110,928.72 by the Defense Logistics Agency's Medical Supply Chain division on July 21, 2025. The delivery order, which is set to be completed by July 22, 2025, covers the supply of Trikafta 100-50-75 mg/150 mg capsules (84-count units). This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at approximately $37,000 by the Defense Logistics Agency on August 25, 2025, for the supply of Trikafta 100-50-75 mg/150 mg pharmaceutical product. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, was issued without a set-aside designation and represents a continuation of DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) for Trikafta 100-50-75 mg/150 mg tablets. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a direct fulfillment of pharmaceutical supply needs for federal healthcare systems. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on August 5, 2025. The delivery order, which expires August 6, 2025, is for Trikafta 100-50-75 mg/150 mg pharmaceutical products. This award was issued without a set-aside designation and represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on July 28, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The order, which carries an ultimate completion date of July 29, 2025, represents a standard pharmaceutical supply transaction without set-aside designation. This delivery order is issued under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $19,314.19 by the Defense Logistics Agency (DLA) on July 18, 2025, for the supply of Trikafta 80-40-60mg/59.5mg packets (14-count). This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a continuation of DMS Pharmaceutical Group's role as a critical pharmaceutical supplier to the federal...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency for Trikafta 100-50-75 mg/150 mg tablets (84 units). This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a direct pharmaceutical supply fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency on August 13, 2025, for the supply of Trikafta 100-50-75 mg/150 mg medications. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a direct pharmaceutical supply to support Department of Defense healthcare operations. The contract was awarded without...
- SPE2DB20D9156Indefinite Delivery Contract
- SPE2DB20D9156-SPE2DB25FH28MDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on September 8, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order carries an ultimate completion date of September 9, 2025, and represents no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion master contract valid through November 2026 that enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in Defense Logistics Agency procurement markets. The company's contract portfolio demonstrates consistent expertise in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. As a registered SAM.gov vendor since 2001, DMS Pharmaceutical Group continues to fulfill specialized pharmaceutical needs across military installations, with this delivery order exemplifying the routine pharmaceutical procurement activities managed through its core indefinite delivery vehicle with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 9/8/25 |